Understanding Pine Bark Extract as an Alternative Treatment (UPBEAT) Study

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the efficacy of Flavangenol® (Toyo Shinyaku, Japan), a pine bark extract, in lowering blood pressure and improving glycemic control and plasma lipoprotein profile.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Stanford University
• Collaborator: Funded by Toyo Shinyaku Co Ltd
• Treatments: Pycnogenols

Criteria

Inclusion Criteria:

• Systolic blood pressure between 125 and 159 mmHg and diastolic blood pressure (DBP) < 100 mmHg

• Body mass index (BMI) 25.0-34.9

• Triglycerides (TG) < 450 mg/dL

• Low Density Lipoprotein (LDL) < 200 mg/dL

• Fasting blood glucose (FBG) < 126 mg/dL

Exclusion Criteria:

• DBP > 95 mmHg

• LDL > 170 mg/dL

• TG > 300 mg/dL

• FBG > 110 mg/dL